All Stories

  1. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults

    Article • Human Vaccines & Immunotherapeutics, November 2017, Taylor & Francis

    Professor Geert Leroux-Roels, Dr Sylvie Bertholet

  2. Adjuvanted herpes zoster subunit vaccine

    Article • Future Virology, January 2016, Future Medicine

    Professor Geert Leroux-Roels

  3. Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination—Heplisav™ compared with Engerix-B® vaccine in adults

    Article • Vaccine, June 2015, Elsevier

    Professor Geert Leroux-Roels

  4. Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model

    Article • Journal of Antimicrobial Chemotherapy, February 2015, Oxford University Press (OUP)

    Professor Geert Leroux-Roels, Lander Foquet

  5. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

    Article • Vaccine, February 2015, Elsevier

    Professor Geert Leroux-Roels

  6. Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

    Article • Human Vaccines & Immunotherapeutics, January 2015, Taylor & Francis

    Professor Geert Leroux-Roels

  7. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials

    Article • Vaccine, January 2015, Elsevier

    Professor Geert Leroux-Roels

  8. Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

    Article • Vaccine, January 2015, Elsevier

    Professor Geert Leroux-Roels

  9. Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1

    Article • Journal of Biological Chemistry, December 2014, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Geert Leroux-Roels

  10. Old and new adjuvants for hepatitis B vaccines

    Article • Medical Microbiology and Immunology, December 2014, Springer Science + Business Media

    Professor Geert Leroux-Roels

  11. Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children

    Article • PLoS ONE, December 2014, PLOS

    Professor Geert Leroux-Roels

  12. Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients

    Article • Journal of Immunological Methods, December 2014, Elsevier

    Professor Geert Leroux-Roels

  13. Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age

    Article • The Pediatric Infectious Disease Journal, December 2014, Wolters Kluwer Health

    Professor Geert Leroux-Roels

  14. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites

    Article • eLife, November 2014, eLife

    Professor Geert Leroux-Roels, Lander Foquet

  15. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study

    Article • Vaccine, November 2014, Elsevier

    Professor Geert Leroux-Roels

  16. Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants within vitroresistance to SR-BI-targeting agents

    Article • Hepatology, July 2014, Wolters Kluwer Health

    Professor Geert Leroux-Roels

  17. Human Skin-Derived Precursor Cells Are Poorly Immunogenic and Modulate the Allogeneic Immune Response

    Article • Stem Cells, July 2014, Wiley

    Professor Geert Leroux-Roels

  18. Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines

    Article • Human Vaccines & Immunotherapeutics, June 2014, Taylor & Francis

    Professor Geert Leroux-Roels

  19. Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from two randomized trials

    Article • Vaccine, June 2014, Elsevier

    Gilbert Donders, Professor Geert Leroux-Roels

  20. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration

    Article • Human Vaccines & Immunotherapeutics, April 2014, Taylor & Francis

    Professor Geert Leroux-Roels

  21. Influenza symptoms and their impact on elderly adults: randomised trial of AS03‐adjuvanted or non‐adjuvanted inactivated trivalent seasonal influenza vaccines

    Article • Influenza and Other Respiratory Viruses, April 2014, Wiley

    Professor Geert Leroux-Roels

  22. Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses

    Article • Journal of Virology, March 2014, ASM Journals

    Professor Geert Leroux-Roels

  23. Metabolism of methylstenbolone studied with human liver microsomes and the uPA+/+-SCID chimeric mouse model

    Article • Biomedical Chromatography, February 2014, Wiley

    Professor Geert Leroux-Roels

  24. Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

    Article • The Journal of Infectious Diseases, January 2014, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  25. Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine

    Article • Clinical and Vaccine Immunology, January 2014, ASM Journals

    Professor Geert Leroux-Roels

  26. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum

    Article • Malaria Journal, January 2014, Springer Science + Business Media

    Professor Geert Leroux-Roels, Lander Foquet

  27. Genetic and Antigenic Typing of Seasonal Influenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efficacy Trial

    Article • Clinical and Vaccine Immunology, December 2013, ASM Journals

    Professor Geert Leroux-Roels

  28. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection

    Article • Journal of Clinical Investigation, December 2013, American Society for Clinical Investigation

    Professor Geert Leroux-Roels, Lander Foquet

  29. In vivo and in vitro metabolism of the synthetic cannabinoid JWH‐200

    Article • Rapid Communications in Mass Spectrometry, August 2013, Wiley

    Professor Geert Leroux-Roels

  30. Polyfunctional CD4+ T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine

    Article • Vaccine, August 2013, Elsevier

    Professor Geert Leroux-Roels

  31. Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults

    Article • Human Vaccines & Immunotherapeutics, June 2013, Taylor & Francis

    Professor Geert Leroux-Roels

  32. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

    Article • The Lancet Infectious Diseases, June 2013, Elsevier

    Professor Geert Leroux-Roels

  33. Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial

    Article • Vaccine, April 2013, Elsevier

    Professor Geert Leroux-Roels

  34. Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

    Article • PLoS ONE, February 2013, PLOS

    Professor Geert Leroux-Roels

  35. In vitro and in vivo metabolisms of 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)

    Article • Forensic Toxicology, February 2013, Springer Science + Business Media

    Professor Geert Leroux-Roels

  36. Clinical evaluation to confirm the manufacturing consistency of three lots of an adjuvanted glycoprotein D genital herpes vaccine in healthy seronegative pre-teen and adolescent girls: A phase III multi-center double-blind randomized trial

    Article • Trials in Vaccinology, January 2013, Elsevier

    Professor Geert Leroux-Roels

  37. Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice

    Article • Malaria Journal, January 2013, Springer Science + Business Media

    Professor Geert Leroux-Roels, Lander Foquet

  38. HIV vaccines

    Article • Human Vaccines & Immunotherapeutics, December 2012, Taylor & Francis

    Professor Geert Leroux-Roels

  39. A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

    Article • The Journal of Infectious Diseases, August 2012, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  40. Influenza vaccines: T-cell responses deserve more attention

    Article • Expert Review of Vaccines, August 2012, Taylor & Francis

    Professor Geert Leroux-Roels, Xavier Saelens

  41. The Sin3a repressor complex is a master regulator of STAT transcriptional activity

    Article • Proceedings of the National Academy of Sciences, July 2012, Proceedings of the National Academy of Sciences

    Professor Geert Leroux-Roels

  42. A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations

    Article • Vaccine, July 2012, Elsevier

    Professor Geert Leroux-Roels

  43. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers

    Article • Human Vaccines & Immunotherapeutics, July 2012, Taylor & Francis

    Professor Geert Leroux-Roels

  44. Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice

    Article • Journal of Hepatology, July 2012, Elsevier

    Professor Geert Leroux-Roels

  45. Blocking HCV entry as potential antiviral therapy

    Article • Future Virology, June 2012, Future Medicine

    Professor Geert Leroux-Roels

  46. A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects

    Article • Vaccine, May 2012, Elsevier

    Professor Geert Leroux-Roels

  47. 827 EXPERIMENTAL HCV VACCINE COMBINING ADENOVIRUS AND PROTEIN ELICITS POTENT T-CELL RESPONSES AND NEUTRALIZING ANTIBODIES IN RODENTS

    Article • Journal of Hepatology, April 2012, Elsevier

    Professor Geert Leroux-Roels

  48. 861 THE LECTIN GRIFFITHSIN HAS ANTIVIRAL ACTIVITY AGAINST HEPATITIS C VIRUS IN VITRO AND IN VIVO

    Article • Journal of Hepatology, April 2012, Elsevier

    Professor Geert Leroux-Roels

  49. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant

    Article • Human Vaccines & Immunotherapeutics, February 2012, Taylor & Francis

    Professor Geert Leroux-Roels

  50. Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum

    Article • Malaria Journal, January 2012, Springer Science + Business Media

    Professor Geert Leroux-Roels

  51. A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo

    Article • Hepatology, December 2011, Wiley

    Professor Geert Leroux-Roels

  52. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity

    Article • Expert Review of Vaccines, December 2011, Taylor & Francis

    Professor Geert Leroux-Roels

  53. Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine

    Article • Journal of Medical Virology, November 2011, Wiley

    Professor Geert Leroux-Roels

  54. Metabolic studies with promagnon, methylclostebol and methasterone in the uPA+/+-SCID chimeric mice

    Article • The Journal of Steroid Biochemistry and Molecular Biology, November 2011, Elsevier

    Professor Geert Leroux-Roels

  55. Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry

    Article • PLoS ONE, October 2011, PLOS

    Professor Geert Leroux-Roels

  56. Griffithsin Has Antiviral Activity against Hepatitis C Virus

    Article • Antimicrobial Agents and Chemotherapy, September 2011, ASM Journals

    Professor Geert Leroux-Roels

  57. Vaccine adjuvants

    Article • Perspectives in Vaccinology, August 2011, Elsevier

    Professor Geert Leroux-Roels

  58. Vaccine development

    Article • Perspectives in Vaccinology, August 2011, Elsevier

    Professor Geert Leroux-Roels

  59. Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine

    Article • Clinical and Vaccine Immunology, July 2011, ASM Journals

    Professor Geert Leroux-Roels

  60. Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 Core-Nonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 NS5A

    Article • Journal of Virology, June 2011, ASM Journals

    Professor Geert Leroux-Roels

  61. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region

    Article • Journal of Viral Hepatitis, April 2011, Wiley

    Professor Geert Leroux-Roels

  62. Vaccine-induced HIV seropositivity: A problem on the rise

    Article • Journal of Clinical Virology, April 2011, Elsevier

    Professor Geert Leroux-Roels

  63. Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials

    Article • Clinical and Vaccine Immunology, March 2011, ASM Journals

    Professor Geert Leroux-Roels

  64. 101 HUMAN MONOCLONAL ANTIBODIES TARGETING SR-BI PREVENT HCV ENTRY AND VIRAL SPREAD IN VIVO

    Article • Journal of Hepatology, March 2011, Elsevier

    Professor Geert Leroux-Roels

  65. In vivoevaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

    Article • Hepatology, February 2011, Wiley

    Professor Geert Leroux-Roels

  66. Head-to-head comparison of pandemic influenza vaccines

    Article • The Lancet Infectious Diseases, February 2011, Elsevier

    Professor Geert Leroux-Roels

  67. Discovery of (7 R )-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6 H -indolo[1,2- e ][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase

    Article • Journal of Medicinal Chemistry, January 2011, American Chemical Society (ACS)

    Professor Geert Leroux-Roels

  68. An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

    Article • Clinical Infectious Diseases, January 2011, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  69. H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

    Article • Journal of Clinical Immunology, December 2010, Springer Science + Business Media

    Professor Geert Leroux-Roels

  70. Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization

    Article • Journal of Virology, December 2010, ASM Journals

    Professor Geert Leroux-Roels

  71. Corrigendum to: “Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults” by Leroux-Roels et al. [Vaccine 26 (2008) 6614–6619]

    Article • Vaccine, November 2010, Elsevier

    Professor Geert Leroux-Roels

  72. Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

    Article • Vaccine, October 2010, Elsevier

    Professor Geert Leroux-Roels

  73. Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults

    Article • Clinical and Vaccine Immunology, September 2010, ASM Journals

    Professor Geert Leroux-Roels

  74. HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2010, Springer Science + Business Media

    Professor Geert Leroux-Roels

  75. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

    Article • Journal of Hepatology, September 2010, Elsevier

    Professor Geert Leroux-Roels

  76. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon–ribavirin combination therapy after 4 weeks of treatment

    Article • European Journal of Gastroenterology & Hepatology, September 2010, Wolters Kluwer Health

    Professor Geert Leroux-Roels, Professor (Associate) Bart L. Haagmans

  77. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

    Article • The Journal of Experimental Medicine, August 2010, Rockefeller University Press

    Professor Geert Leroux-Roels

  78. Unmet needs in modern vaccinology

    Article • Vaccine, August 2010, Elsevier

    Professor Geert Leroux-Roels

  79. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule wi...

    Article • Human Vaccines, August 2010, Taylor & Francis

    Professor Geert Leroux-Roels

  80. Inactivated Split-Virion Seasonal Influenza Vaccine (Fluarix®)

    Article • Drugs, August 2010, Springer Science + Business Media

    Professor Geert Leroux-Roels

  81. Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice

    Article • Immunology, June 2010, Wiley

    Professor Geert Leroux-Roels

  82. Challenge Pools of Hepatitis C Virus Genotypes 1–6 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver–Chimeric Mouse Models

    Article • The Journal of Infectious Diseases, May 2010, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  83. Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study

    Article • Vaccine, January 2010, Elsevier

    Professor Geert Leroux-Roels

  84. Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies

    Article • Journal of General Virology, November 2009, Society for General Microbiology

    Professor Geert Leroux-Roels

  85. Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults

    Article • Vaccine, November 2009, Elsevier

    Professor Geert Leroux-Roels

  86. Steroid metabolism in chimeric mice with humanized liver

    Article • Drug Testing and Analysis, November 2009, Wiley

    Professor Geert Leroux-Roels

  87. Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism

    Article • Drug Testing and Analysis, November 2009, Wiley

    Professor Geert Leroux-Roels

  88. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry

    Article • Steroids, October 2009, Elsevier

    Professor Geert Leroux-Roels, Professor FELIX HERNANDEZ

  89. uPA+/+-SCID Mouse with Humanized Liver as a Model for In Vivo Metabolism of Exogenous Steroids: Methandienone as a Case Study

    Article • Clinical Chemistry, October 2009, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  90. The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione

    Article • Drug Metabolism and Disposition, September 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Geert Leroux-Roels

  91. HCV Animal Models: A Journey of More than 30 Years

    Article • Viruses, September 2009, MDPI AG

    Professor Geert Leroux-Roels

  92. Detection and Characterization of a New Metabolite of 17α-Methyltestosterone

    Article • Drug Metabolism and Disposition, August 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Geert Leroux-Roels, Professor FELIX HERNANDEZ

  93. Mumps outbreaks in highly vaccinated populations: What makes good even better?

    Article • Human Vaccines, July 2009, Taylor & Francis

    Professor Geert Leroux-Roels

  94. Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data

    Article • Expert Opinion on Biological Therapy, June 2009, Informa Healthcare

    Professor Geert Leroux-Roels

  95. Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations

    Article • PLoS Pathogens, June 2009, PLOS

    Professor Geert Leroux-Roels, Ralf Bartenschlager

  96. Evaluation of Cellular Immunity to Mumps in Vaccinated Individuals with or without Circulating Antibodies up to 16 Years after Their Last Vaccination

    Article • The Journal of Infectious Diseases, May 2009, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  97. Stimulation of erythropoietin production after controlled blood loss

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Geert Leroux-Roels

  98. Current status and progress of prepandemic and pandemic influenza vaccine development

    Article • Expert Review of Vaccines, April 2009, Taylor & Francis

    Professor Geert Leroux-Roels

  99. Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic

    Article • Vaccine, January 2009, Elsevier

    Professor Geert Leroux-Roels

  100. Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice

    Article • Hepatology, December 2008, Wiley

    Professor Geert Leroux-Roels

  101. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults

    Article • Vaccine, December 2008, Elsevier

    Professor Geert Leroux-Roels

  102. Vaccines Adjuvanted with Adjuvant Systems - from Concept to Clinical Evidence

    Article • International Journal of Infectious Diseases, December 2008, Elsevier

    Professor Geert Leroux-Roels

  103. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

    Article • Nephrology Dialysis Transplantation, October 2008, Oxford University Press (OUP)

    Professor Geert Leroux-Roels, Prof. Carmine Zoccali

  104. Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication

    Article • Journal of Virology, September 2008, ASM Journals

    Professor Geert Leroux-Roels, Ralf Bartenschlager

  105. An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

    Article • The Journal of Infectious Diseases, September 2008, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  106. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

    Article • Hepatology, July 2008, Wiley

    Professor Geert Leroux-Roels

  107. Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit

    Article • Clinical and Vaccine Immunology, March 2008, ASM Journals

    Professor Geert Leroux-Roels

  108. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

    Article • Vaccine, March 2008, Elsevier

    Professor Geert Leroux-Roels

  109. Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

    Article • PLoS ONE, February 2008, PLOS

    Professor Geert Leroux-Roels

  110. Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain

    Article • Hepatology, January 2008, Wiley

    Professor Geert Leroux-Roels

  111. Development and validation of a quantitative gas chromatography–mass spectrometry method for the detection of endogenous androgens in mouse urine

    Article • Journal of Chromatography A, January 2008, Elsevier

    Professor Geert Leroux-Roels

  112. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine

    Article • Vaccine, December 2007, Elsevier

    Professor Geert Leroux-Roels

  113. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

    Article • Hepatology, October 2007, Wiley

    Professor Geert Leroux-Roels

  114. Ultra-Rapid Cardiotoxicity of the Hepatitis C Virus Protease Inhibitor BILN 2061 in the Urokinase-Type Plasminogen Activator Mouse

    Article • Gastroenterology, October 2007, Elsevier

    Professor Geert Leroux-Roels

  115. Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant

    Article • Journal of Virology, September 2007, ASM Journals

    Professor Geert Leroux-Roels, Ralf Bartenschlager

  116. Long-term persistence of antibodies after one or two doses of MMR-vaccine

    Article • Vaccine, September 2007, Elsevier

    Professor Geert Leroux-Roels

  117. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

    Article • The Lancet, August 2007, Elsevier

    Professor Geert Leroux-Roels

  118. Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients

    Article • Antiviral Research, August 2007, Elsevier

    Professor Geert Leroux-Roels

  119. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix™) in adults

    Article • Travel Medicine and Infectious Disease, May 2007, Elsevier

    Professor Geert Leroux-Roels

  120. The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection

    Article • Journal of Immunological Methods, March 2007, Elsevier

    Professor Geert Leroux-Roels

  121. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women

    Article • International Journal of STD & AIDS, March 2007, SAGE Publications

    Professor Geert Leroux-Roels

  122. Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity

    Article • Journal of Virology, January 2007, ASM Journals

    Professor Geert Leroux-Roels

  123. Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C

    Article • Journal of Medical Virology, January 2007, Wiley

    Professor Geert Leroux-Roels

  124. Contamination of a Recombinant Hepatitis B Virus Nucleocapsid Preparation with a Human B-Cell Activator

    Article • Journal of Virology, December 2006, ASM Journals

    Professor Geert Leroux-Roels

  125. Partial Delipidation Improves the T-Cell Antigenicity of Hepatitis B Virus Surface Antigen

    Article • Journal of Virology, April 2006, ASM Journals

    Professor Geert Leroux-Roels

  126. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection

    Article • Clinica Chimica Acta, April 2006, Elsevier

    Professor Geert Leroux-Roels

  127. Immune Suppression Uncovers Endogenous Cytopathic Effects of the Hepatitis B Virus

    Article • Journal of Virology, March 2006, ASM Journals

    Professor Geert Leroux-Roels

  128. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

    Article • Proceedings of the National Academy of Sciences, February 2006, Proceedings of the National Academy of Sciences

    Professor Geert Leroux-Roels

  129. Aanpak bij perinatale hepatitis C-virusinfectie

    Article • Tijdschrift voor Geneeskunde, January 2006, Peeters Publishers

    Professor Geert Leroux-Roels

  130. P.026 In vitro inhibition of HBsAg secretion by single-domain intrabodies

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Geert Leroux-Roels

  131. P.341 Immunity to hepatitis B vaccine in asymptomatic HIV-positive South African babies

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Geert Leroux-Roels

  132. O.055 The human liver-uPA-SCID mouse: a chimeric rodent model for the study of viral hepatitis

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Geert Leroux-Roels

  133. Aanpak bij perinatale hepatitis C-virusinfectie

    Article • Tijdschrift voor Geneeskunde, January 2006, Peeters Publishers

    Professor Geert Leroux-Roels

  134. O.053 The human liver uPA-SCID mouse, a preclinical model to test anti-hepatitis C compounds

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Geert Leroux-Roels

  135. The Role of Heparan Sulfate and TLR2 in Cytokine Induction by Hepatitis B Virus Capsids

    Article • The Journal of Immunology, November 2005, The American Association of Immunologists

    Professor Geert Leroux-Roels

  136. Comparison of Qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and Quantitative (COBAS AMPLICOR HCV Monitor 2.0 versus VERSANT HCV RNA 3.0) Assays for Hepatitis C Virus (HCV) RNA Detection and Quantification: Impact on Diagnosis and Treatmen...

    Article • Journal of Clinical Microbiology, June 2005, ASM Journals

    Professor Geert Leroux-Roels

  137. Development of prophylactic and therapeutic vaccines against hepatitis C virus

    Article • Expert Review of Vaccines, June 2005, Taylor & Francis

    Professor Geert Leroux-Roels

  138. The duration of in vitro stimulation with recall antigens determines the subset distribution of interferon-γ-producing lymphoid cells: A kinetic analysis using the Interferon-γ Secretion Assay™

    Article • Journal of Immunological Methods, June 2005, Elsevier

    Professor Geert Leroux-Roels

  139. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

    Article • Vaccine, April 2005, Elsevier

    Professor Geert Leroux-Roels

  140. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

    Article • Hepatology, April 2005, Wiley

    Professor Geert Leroux-Roels

  141. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation

    Article • April 2005, Wiley

    Professor Geert Leroux-Roels

  142. Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation

    Article • Clinical & Experimental Immunology, April 2005, Wiley

    Professor Geert Leroux-Roels

  143. Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection

    Article • Human Vaccines, March 2005, Taylor & Francis

    Professor Geert Leroux-Roels

  144. A temperature-dependent inhibitory activity of serum on the capacity of Saccharomyces cerevisiae-derived hepatitis B surface antigen to bind to monocytes

    Article • Archives of Virology, October 2004, Springer Science + Business Media

    Professor Geert Leroux-Roels, Professor Francisco Gavilanes, Dr Francisco Gavilanes

  145. A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers

    Article • Vaccine, August 2004, Elsevier

    Professor Geert Leroux-Roels

  146. Prevention of hepatitis C virus infection*

    Article • Journal of Viral Hepatitis, May 2004, Wiley

    Professor Geert Leroux-Roels, Professor Daniel D Shouval

  147. The interferon gamma secretion assay: a reliable tool to study interferon gamma production at the single cell level

    Article • Journal of Immunological Methods, March 2004, Elsevier

    Professor Geert Leroux-Roels

  148. Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *

    Article • Journal of Viral Hepatitis, November 2003, Wiley

    Professor Geert Leroux-Roels

  149. Immunogenetics of the response to HBsAg vaccination

    Article • Autoimmunity Reviews, September 2003, Elsevier

    Professor Geert Leroux-Roels

  150. Hepatitis A booster vaccination: is there a need?

    Article • The Lancet, September 2003, Elsevier

    Professor Geert Leroux-Roels, Professor Daniel D Shouval

  151. Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients

    Article • Journal of Medical Virology, August 2003, Wiley

    Professor Geert Leroux-Roels

  152. A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice

    Article • Biochemical and Biophysical Research Communications, August 2003, Elsevier

    Professor Geert Leroux-Roels

  153. Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity

    Article • Journal of Medical Virology, June 2003, Wiley

    Professor Geert Leroux-Roels

  154. Antifibrotic activity correlates with immune response to E1 therapeutic vaccination in 24 patients with chronic active hepatitis C

    Article • Journal of Hepatology, April 2003, Elsevier

    Professor Geert Leroux-Roels

  155. Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?

    Article • Trends in Immunology, March 2003, Elsevier

    Professor Geert Leroux-Roels

  156. Evaluation of a New Rapid Test for the Combined Detection of Hepatitis B Virus Surface Antigen and Hepatitis B Virus e Antigen

    Article • Journal of Clinical Microbiology, December 2002, ASM Journals

    Professor Geert Leroux-Roels

  157. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population

    Article • Vaccine, November 2002, Elsevier

    Professor Geert Leroux-Roels

  158. Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes

    Article • Biochemical and Biophysical Research Communications, September 2002, Elsevier

    Professor Geert Leroux-Roels

  159. Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients

    Article • Alimentary Pharmacology & Therapeutics, August 2002, Wiley

    Professor Geert Leroux-Roels

  160. Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant

    Article • Vaccine, June 2002, Elsevier

    Professor Geert Leroux-Roels

  161. Elevated serum iron indices in haptoglobin phenotype 2-2 individuals being homozygous for the HFE missense mutation

    Article • Journal of Hepatology, April 2002, Elsevier

    Professor Geert Leroux-Roels

  162. Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels

    Article • Journal of Hepatology, March 2002, Elsevier

    Professor Geert Leroux-Roels

  163. In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model

    Article • Journal of Virology, December 2001, ASM Journals

    Professor Geert Leroux-Roels

  164. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients

    Article • Journal of Hepatology, December 2001, Elsevier

    Professor Geert Leroux-Roels

  165. Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C

    Article • September 2001, Wolters Kluwer Health

    Professor Geert Leroux-Roels

  166. Long‐term persistence of antibodies induced by vaccination and safety follow‐up, with the first combined vaccine against hepatitis A and B in children and adults

    Article • Journal of Medical Virology, September 2001, Wiley

    Professor Geert Leroux-Roels

  167. PREVENTION OF HEPATITIS B INFECTIONS : VACCINATION AND ITS LIMITATIONS

    Article • Acta Clinica Belgica, August 2001, Taylor & Francis

    Professor Geert Leroux-Roels

  168. Hepatitis B Virus Core Antigen Binds and Activates Naive Human B Cells In Vivo: Studies with a Human PBL-NOD/SCID Mouse Model

    Article • Journal of Virology, July 2001, ASM Journals

    Professor Geert Leroux-Roels

  169. Molecular Basis for the Interaction of the Hepatitis B Virus Core Antigen with the Surface Immunoglobulin Receptor on Naive B Cells

    Article • Journal of Virology, July 2001, ASM Journals

    Professor Geert Leroux-Roels

  170. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen

    Article • Journal of Biomedical Science, May 2001, Springer Science + Business Media

    Professor Geert Leroux-Roels

  171. Polyclonal anti-HBs antibodies of adult vaccinees bind to G145R and other naturally occurring mutant HBsAg

    Article • Gastroenterology, April 2001, Elsevier

    Professor Geert Leroux-Roels

  172. Human B Cell Growth and Differentiation in the Spleen of Immunodeficient Mice

    Article • The Journal of Immunology, March 2001, The American Association of Immunologists

    Professor Geert Leroux-Roels

  173. Vaccine- and Hepatitis B Immune Globulin-Induced Escape Mutations of Hepatitis B Virus Surface Antigen

    Article • Journal of Biomedical Science, January 2001, Springer Science + Business Media

    Professor Geert Leroux-Roels

  174. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

    Article • Journal of Medical Virology, January 2001, Wiley

    Professor Geert Leroux-Roels

  175. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines

    Article • Clinical & Experimental Immunology, December 2000, Wiley

    Professor Geert Leroux-Roels

  176. A comparison of two commercial recombinant vaccines for hepatitis B in adolescents

    Article • Vaccine, November 2000, Elsevier

    Professor Geert Leroux-Roels

  177. Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor β -chain

    Article • Clinical & Experimental Immunology, October 2000, Wiley

    Professor Geert Leroux-Roels

  178. Hepatitis and Dialysis

    Article • September 2000, Taylor & Francis

    Professor Geert Leroux-Roels

  179. A hepatitis B vaccine formulated with a novel adjuvant system

    Article • Vaccine, April 2000, Elsevier

    Professor Geert Leroux-Roels

  180. Ribavirin induced hemolysis is haptoglobin dependent

    Article • Gastroenterology, April 2000, Elsevier

    Professor Geert Leroux-Roels

  181. Daily induction treatment with alfa2b interferon in naive chronic hepatitis c patients results in a higher early response, a controlled multicenter randomized trial

    Article • Gastroenterology, April 2000, Elsevier

    Professor Geert Leroux-Roels

  182. Reactivity pattern of a human monoclonal antibody against recombinant hepatitis B vaccine to hbsag immune escape mutants

    Article • Gastroenterology, April 2000, Elsevier

    Professor Geert Leroux-Roels

  183. Association between the Cys282Tyr missense mutation and the haptoglobin phenotype polymorphism in patients with chronic hepatitis C

    Article • Gastroenterology, April 2000, Elsevier

    Professor Geert Leroux-Roels

  184. Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers

    Article • Journal of Medical Virology, February 2000, Wiley

    Professor Geert Leroux-Roels

  185. Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers

    Article • Journal of Medical Virology, February 2000, Wiley

    Professor Geert Leroux-Roels

  186. Effects of Re-Arterialization on Early Graft Function and Regeneration in the Rat Model of Heterotopic Auxiliary Liver Transplantation

    Article • European Surgical Research, January 2000, Karger Publishers

    Professor Geert Leroux-Roels

  187. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice

    Article • Clinical & Experimental Immunology, January 2000, Wiley

    Professor Geert Leroux-Roels

  188. The first combined vaccine against hepatitis A and B: an overview

    Article • Vaccine, January 1999, Elsevier

    Professor Geert Leroux-Roels

  189. Evaluation of Graft Viability in Heterotopic Auxiliary Liver Transplantation in the Rat

    Article • Journal of Investigative Surgery, January 1999, Taylor & Francis

    Professor Geert Leroux-Roels

  190. De immunologie van multiple sclerose

    Article • Tijdschrift voor Geneeskunde, January 1999, Peeters Publishers

    Professor Geert Leroux-Roels

  191. De immunologie van multiple sclerose

    Article • Tijdschrift voor Geneeskunde, January 1999, Peeters Publishers

    Professor Geert Leroux-Roels

  192. Virale hepatitis van A tot G. Diagnostische aspecten.

    Article • Tijdschrift voor Geneeskunde, January 1999, Peeters Publishers

    Professor Geert Leroux-Roels

  193. Virale hepatitis van A tot G. Diagnostische aspecten.

    Article • Tijdschrift voor Geneeskunde, January 1999, Peeters Publishers

    Professor Geert Leroux-Roels

  194. Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice

    Article • European Journal of Immunology, October 1998, Wiley

    Professor Geert Leroux-Roels

  195. Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

    Article • Journal of Hepatology, June 1998, Elsevier

    Professor Geert Leroux-Roels

  196. Response to hepatitis B vaccine: multiple HLA genes are involved

    Article • Tissue Antigens, June 1998, Wiley

    Professor Geert Leroux-Roels

  197. Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?

    Article • Multiple Sclerosis Journal, June 1998, SAGE Publications

    Professor Geert Leroux-Roels

  198. Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

    Article • Vaccine, April 1998, Elsevier

    Professor Geert Leroux-Roels

  199. Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?

    Article • Multiple Sclerosis Journal, March 1998, SAGE Publications

    Professor Geert Leroux-Roels

  200. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B

    Article • Journal of Hepatology, January 1998, Elsevier

    Professor Geert Leroux-Roels

  201. Virale hepatitis van A tot G. Diagnostische aspecten

    Article • Tijdschrift voor Geneeskunde, January 1998, Peeters Publishers

    Professor Geert Leroux-Roels

  202. Virale hepatitis van A tot G. Diagnostische aspecten

    Article • Tijdschrift voor Geneeskunde, January 1998, Peeters Publishers

    Professor Geert Leroux-Roels

  203. Het klinisch verloop van acute virale hepatitis bij kinderen

    Article • Tijdschrift voor Geneeskunde, January 1998, Peeters Publishers

    Professor Geert Leroux-Roels

  204. Het klinisch verloop van acute virale hepatitis bij kinderen

    Article • Tijdschrift voor Geneeskunde, January 1998, Peeters Publishers

    Professor Geert Leroux-Roels

  205. Diagnostic Performance of the EMIT-tox(R) Benzodiazepine Immunoassay, FPIA Serum Benzodiazepine Immunoassay, and Radioreceptor Assay in Suspected Acute Poisoning

    Article • Journal of Analytical Toxicology, January 1998, Oxford University Press (OUP)

    Professor Geert Leroux-Roels

  206. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults

    Article • Vaccine, November 1997, Elsevier

    Professor Geert Leroux-Roels

  207. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences 2. Immunogenicity in poor responders to hepatitis B vaccines

    Article • Vaccine, November 1997, Elsevier

    Professor Geert Leroux-Roels

  208. Combination Hepatitis A-Hepatitis B Vaccine

    Article • BioDrugs, September 1997, Springer Science + Business Media

    Professor Geert Leroux-Roels

  209. J.P. Van Haelst

    Article • Nuclear Medicine Communications, May 1997, Wolters Kluwer Health

    Professor Geert Leroux-Roels

  210. Distribution of Lymphocyte Subsets in Bone Marrow and Peripheral Blood Is Associated with Haptoglobin Type. Binding of Haptoglobin to the B-Cell Lectin CD22

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1997, De Gruyter

    Professor Geert Leroux-Roels

  211. In vitro TNF-α, IL-2 and IFN-γ production as markers of relapses in multiple sclerosis

    Article • Clinical Neurology and Neurosurgery, November 1996, Elsevier

    Professor Geert Leroux-Roels

  212. Genetic polymorphisms and erythrocyte sodium-lithium countertransport in essential hypertension

    Article • Clinica Chimica Acta, November 1996, Elsevier

    Professor Geert Leroux-Roels

  213. Haptoglobin polymorphism and chronic hepatitis C

    Article • Journal of Hepatology, July 1996, Elsevier

    Professor Geert Leroux-Roels

  214. Hepatitis C virus (HCV) genotype analysis in apparently healthy anti- HCV-positive Parisian blood donors

    Article • Transfusion, June 1996, Wiley

    Professor Geert Leroux-Roels

  215. Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission

    Article • Kidney International, March 1996, Elsevier

    Professor Geert Leroux-Roels

  216. Comparison of a Recombinant Thromboplastin with Thrombotest® for Oral Anticoagulant Control

    Article • Pathophysiology of Haemostasis and Thrombosis, January 1996, Karger Publishers

    Professor Geert Leroux-Roels

  217. Safety and Immunogenicity of a Combined Hepatitis A and Hepatitis B Vaccine in Young Healthy Adults

    Article • Scandinavian Journal of Gastroenterology, January 1996, Taylor & Francis

    Professor Geert Leroux-Roels

  218. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa

    Article • Hepatology, January 1996, Wiley

    Professor Geert Leroux-Roels

  219. Refractory hypertension is associated with the haptoglobin 2-2 phenotype

    Article • Journal of Cardiovascular Risk, April 1995, Wolters Kluwer Health

    Professor Geert Leroux-Roels

  220. Evolution of HCV-specific T cell responses and in vivo and in vitro TNFα and interferon-γ production in chronic HCV patients treated with high doses of interferon-α

    Article • Gastroenterology, April 1995, Elsevier

    Professor Geert Leroux-Roels

  221. Refractory Hypertension is Associated with the Haptoglobin 2-2 Phenotype

    Article • European Journal of Cardiovascular Prevention & Rehabilitation, April 1995, SAGE Publications

    Professor Geert Leroux-Roels

  222. Neopterin-levels in multiple sclerosis

    Article • Journal of Neuroimmunology, October 1994, Elsevier

    Professor Geert Leroux-Roels

  223. T-lymphocyte subpopulations in multiple sclerosis

    Article • Journal of Neuroimmunology, October 1994, Elsevier

    Professor Geert Leroux-Roels

  224. Cytokine production in human whole blood cell cultures of patients with multiple sclerosis: Evidence for Th1 or Th2?

    Article • Journal of Neuroimmunology, October 1994, Elsevier

    Professor Geert Leroux-Roels

  225. Glomerular filtration rate and creatinine production in adult icteric patients

    Article • Clinica Chimica Acta, January 1994, Elsevier

    Professor Geert Leroux-Roels

  226. Hepatitis B virus-specific cytotoxic T lymphocyte responses in patients with acute and chronic hepatitis B virus infection

    Article • Journal of Hepatology, January 1994, Elsevier

    Professor Geert Leroux-Roels

  227. A Method to Detect Hepatitis B Virus-specific Cytotoxic T Lymphocytes in Patients with Acute and Chronic HBV Infection

    Article • January 1994, Springer Science + Business Media

    Professor Geert Leroux-Roels

  228. Posttranslational Heterogeneity of Bone Alkaline Phosphatase in Metabolic Bone Disease

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1994, De Gruyter

    Professor Geert Leroux-Roels

  229. Haptoglobin polymorphism and complications in established essential arterial hypertension

    Article • Journal of Hypertension, August 1993, Wolters Kluwer Health

    Professor Geert Leroux-Roels

  230. Haptoglobin polymorphism and the immune response after hepatitis B vaccination

    Article • Vaccine, January 1993, Elsevier

    Professor Geert Leroux-Roels

  231. Laboratory Assessment of Five Glucose Meters Designed for Self-Monitoring of Blood Glucose Concentration

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1993, De Gruyter

    Professor Geert Leroux-Roels

  232. Glycation of human tissue and serum creatine kinase

    Article • Clinica Chimica Acta, October 1992, Elsevier

    Professor Geert Leroux-Roels

  233. Activation of the clotting cascade in peripheral arterial occlusive disease

    Article • Thrombosis Research, January 1992, Elsevier

    Professor Geert Leroux-Roels

  234. Plasma urokinase levels in cardiovascular diseases

    Article • Thrombosis Research, January 1992, Elsevier

    Professor Geert Leroux-Roels

  235. Low serum creatine kinase in patients with infective endocarditis

    Article • Clinica Chimica Acta, March 1991, Elsevier

    Professor Geert Leroux-Roels

  236. Evaluation of the Automated Haematology Analyser Sysmex NE-8000

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1991, De Gruyter

    Professor Geert Leroux-Roels

  237. Can Creatine Predict Further Major Cardiovascular Events after Acute Myocardial Infarction?

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, January 1991, SAGE Publications

    Professor Geert Leroux-Roels

  238. In-vitro production of cytokines in blood

    Article • The Lancet, November 1990, Elsevier

    Professor Geert Leroux-Roels

  239. Tumor necrosis factor in sepsis

    Article • JAMA, March 1990, American Medical Association (AMA)

    Professor Geert Leroux-Roels

  240. Tumor Necrosis Factor in Sepsis

    Article • JAMA, March 1990, American Medical Association (AMA)

    Professor Geert Leroux-Roels

  241. Release of tissue plasminogen activator during coronary angioplasty

    Article • The Lancet, March 1990, Elsevier

    Professor Geert Leroux-Roels

  242. Plasminogen activator inhibitor type 1 antigen plasma levels compared to tumors necrosis factor-α in vivo

    Article • Fibrinolysis and Proteolysis, January 1990, Elsevier

    Professor Geert Leroux-Roels

  243. Alloinduced suppression and cytotoxicity: two functions of a single cell

    Article • Immunology Letters, May 1987, Elsevier

    Professor Geert Leroux-Roels

  244. Molecular and Cellular Biology of Tumor Necrosis Factor, Interferon-γ, and their Synergism

    Article • January 1987, Springer Science + Business Media

    Professor Geert Leroux-Roels

  245. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-γ, on a syngeneic murine melanoma

    Article • International Journal of Cancer, November 1986, Wiley

    Professor Geert Leroux-Roels

  246. Lymphokines and Monokines in Anti-cancer Therapy

    Article • Cold Spring Harbor Symposia on Quantitative Biology, January 1986, Cold Spring Harbor Laboratory Press

    Professor Geert Leroux-Roels

  247. Production of two distinct and independent hepatic immunoregulatory molecules by the perfused rat liver

    Article • Hepatology, September 1985, Wiley

    Professor Geert Leroux-Roels

  248. Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity

    Article • Clinica Chimica Acta, June 1984, Elsevier

    Professor Geert Leroux-Roels